Literature DB >> 28128018

German guideline on the diagnosis and treatment of peripheral artery disease - a comprehensive update 2016.

Holger Lawall1, Peter Huppert2, Christine Espinola-Klein3, Claudia Silke Zemmrich4, Gerhard Ruemenapf5.   

Abstract

The prevalence of peripheral artery disease (PAD) is increasing worldwide and is strongly age-related, affecting about 20 % of Germans over 70 years of age. Recent advances in endovascular and surgical techniques as well as clinical study results on comparative treatment methods strengthened the need for a comprehensive review of the published evidence for diagnosis, management, and prevention of PAD. The interdisciplinary guideline exclusively covers distal aorta and atherosclerotic lower extremity artery disease. A systematic literature review and formal consensus finding process, including delegated members of 22 medical societies and two patient self-support organisations were conducted and supervised by the Association of Scientific Medical Societies in Germany, AWMF. Three levels of recommendation were defined, A = "is recommended/indicated", B = "should be considered", C = "may be considered", means agreement of expert opinions due to lack of evidence. Altogether 294 articles, including 34 systematic reviews and 98 RCTs have been analysed. The key diagnostic tools and treatment basics have been defined. In patients with intermittent claudication endovascular and/or surgical techniques are treatment options depending on appropriate individual morphology and patient preference. In critical limb ischaemia, revascularisation without delay by means of the most appropriate technique is key. If possible and reasonable, endovascular procedures should be applied first. The TASC classification is no longer recommended as the base of therapeutic decision process due to advances in endovascular techniques and new crural therapeutic options. Limited new data on rehabilitation and follow-up therapies have been integrated. The article summarises major new aspects of PAD treatment from the updated German Guidelines for Diagnosis and Treatment of PAD. Limited scientific evidence still calls for randomised clinical trials to close the present gap of evidence.

Entities:  

Keywords:  Peripheral artery disease; diagnosis; guideline update; treatment; update

Mesh:

Substances:

Year:  2017        PMID: 28128018     DOI: 10.1024/0301-1526/a000603

Source DB:  PubMed          Journal:  Vasa        ISSN: 0301-1526            Impact factor:   1.961


  9 in total

Review 1.  The role of hepcidin and iron homeostasis in atherosclerosis.

Authors:  Florian Wunderer; Lisa Traeger; Haakon H Sigurslid; Patrick Meybohm; Donald B Bloch; Rajeev Malhotra
Journal:  Pharmacol Res       Date:  2020-01-25       Impact factor: 7.658

2.  Excimer laser ablation combined with drug-coated balloon versus drug-coated balloon in the treatment of de novo atherosclerotic lesions in lower extremities (ELABORATE): study protocol for a real-world clinical trial.

Authors:  Xiaolang Jiang; Longhua Fan; Bin Chen; Junhao Jiang; Jianjun Liu; Guanyu Qiao; Shuai Ju; Yun Shi; Tao Ma; Changpo Lin; Gang Fang; Daqiao Guo; Xin Xu; Zhihui Dong; Weiguo Fu
Journal:  BMC Cardiovasc Disord       Date:  2022-07-16       Impact factor: 2.174

3.  Successful recanalization of long femoro-crural occlusive disease after failed bypass surgery.

Authors:  Grigorios Korosoglou; Tom Eisele; Dorothea Raupp; Christoph Eisenbach; Sorin Giusca
Journal:  World J Cardiol       Date:  2017-12-26

4.  A prescription support-tool for chronic management of oral antithrombotic combinations in adults based on a systematic review of international guidelines.

Authors:  Lorene Zerah; René-Sosata Bun; Sylvie Guillo; Jean-Philippe Collet; Dominique Bonnet-Zamponi; Florence Tubach
Journal:  PLoS One       Date:  2019-02-14       Impact factor: 3.240

5.  Feasibility and safety of automated CO2 angiography in peripheral arterial interventions.

Authors:  Rohit Philip Thomas; Simon Viniol; Alexander Marc König; Irene Portig; Zaher Swaid; Andreas H Mahnken
Journal:  Medicine (Baltimore)       Date:  2021-01-15       Impact factor: 1.817

6.  Evaluation of Hyperspectral Imaging for Follow-Up Assessment after Revascularization in Peripheral Artery Disease.

Authors:  Eberhard Grambow; Niels Arne Sandkühler; Justus Groß; Daniel G E Thiem; Michael Dau; Matthias Leuchter; Malte Weinrich
Journal:  J Clin Med       Date:  2022-01-30       Impact factor: 4.241

7.  Retinal and choriocapillaris perfusion are associated with ankle-brachial-pressure-index and Fontaine stage in peripheral arterial disease.

Authors:  Maximilian W M Wintergerst; Peyman Falahat; Robert P Finger; Nadjib Schahab; Frank G Holz; Christian Schaefer
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

8.  Risk Factor Management in Non-Metropolitan Patients with Coronary and Peripheral Artery Disease - A Protocol of a Prospective, Multi-Center, Quality Improvement Strategy.

Authors:  Claudia Zemmrich; Peter Bramlage; Philipp Hillmeister; Mesud Sacirovic; Ivo Buschmann
Journal:  Vasc Health Risk Manag       Date:  2021-05-27

Review 9.  Sulodexide improves pain-free walking distance in patients with lower extremity peripheral arterial disease: A systematic review and meta-analysis.

Authors:  Antonio Vittorino Gaddi; Fabio Capello; Oana Florentina Gheorghe-Fronea; Simone Fadda; Roxana Oana Darabont
Journal:  JRSM Cardiovasc Dis       Date:  2020-02-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.